Carl Zeiss Meditec AG
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Carl Zeiss Meditec AG
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Frequently asked questions
To buy Carl Zeiss Meditec AG stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Carl Zeiss Meditec AG by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Carl Zeiss Meditec AG is AFX:xetr. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Carl Zeiss Meditec AG has its primary listing on Deutsche Börse (XETRA). You can trade Carl Zeiss Meditec AG with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Carl Zeiss Meditec AG is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Carl Zeiss Meditec AG as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Carl Zeiss Meditec AG.